Intestinal lipid'derived signals that sense dietary fat

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 891-898

  DiPatrizio, Nicholas V ^a,c   Piomelli, Daniele ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; FATTY ACID; LIPID; N OLEOYLETHANOLAMINE; FAT INTAKE;

FAT CONTENT; FAT INTAKE; FOOD INTAKE; HUNGER; PRIORITY JOURNAL; REVIEW; SATIETY; SMALL INTESTINE; TASTE; ANIMAL; EATING; HUMAN; INNERVATION; INTESTINE; METABOLISM; PHYSIOLOGY; SOLITARY TRACT NUCLEUS;

ANIMALS; APPETITE REGULATION; DIETARY FATS; EATING; ENDOCANNABINOIDS; HUMANS; INTESTINES; SATIATION; SOLITARY NUCLEUS; TASTE;

EID: 84924040089     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76302     Document Type: Review

References (130)

1. Leonard WR, Snodgrass JJ, Robertson ML. Evolutionary perspectives on fat ingestion and metabolism in humans. In: Montmayeur JP, le Coutre J, eds. Fat Detection: Taste, Texture, and Post Ingestive Effects. Boca Raton, Florida, USA: CRC Press; 2010:Chapter 1.
2. Muskiet FAJ. Pathophysiology and evolutionary aspects of dietary fats and long-chain polyunsaturated fatty acids across the life cycle. In: Montmayeur JP, le Coutre J, eds. Fat Detection: Taste, Texture, and Post Ingestive Effects. Boca Raton, Florida, USA: CRC Press; 2010:Chapter 2.
3. Piomelli D, Astarita G, Rapaka R. A neuroscientist's guide to lipidomics. Nat Rev Neurosci. 2007;8(10):743-754.
4. DiPatrizio NV, Piomelli D. The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci. 2012;35(7):403-411.
5. Neel JV. Diabetes mellitus: a "thrifty " genotype ren dered detrimental by "progress"? Am J Hum Genet. 1962;(14):353-362.
6. Diamond J. The World Until Yesterday: What Can We Learn From Traditional Societies. New York, New York, USA: Penguin Press; 2012.
7. Zhang M, Gosnell BA, Kelley AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther. 1998;285(2):908-914.
8. Baldo BA, Pratt WE, Kelley AE. Control of fat intake by striatal opioids. In: Montmayeur JP, le Coutre J, eds. Fat Detection: Taste, Texture, and Post Ingestive Effects. Boca Raton, Florida: CRC Press; 2010:Chapt er 13.
9. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS data brief, no 82
10. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci. 2012;15(10):1350-1355.
11. Morganstern I, Chang GQ, Karatayev O, Leibo witz SF. Increased orexin melanin-concentrating hormone expression in the perifornical lateral hypothalamus of rats prone to overconsuming a fat-rich diet. Pharmacol Biochem Behav. 2010;96(4):413-422.
12. Piomelli D. More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology. 2014;76(pt B):228-234.
13. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol. 2005;(168):299-325.
14. Bajzer M, et al. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mic e. Diabetologia. 2011;54(12):3121-3131.
15. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.
16. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003;26(9):507-513.
17. Mahler SV, Smith KS, Berridge KC. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ' liking' of a sweet reward. Neuropsychopharmacology. 2007;32(11):2267-2278.
18. Quarta C, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab. 2010;11(4):273-285.
19. Jung KM, et al. 2-Arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab. 2012;15(3):299-310.
20. Kunos G, Tam J. The case for peripheral CB receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. Br J Pharmacol. 2011;163(7):1423-1431.
21. Pertwee RG, Fernando SR, Nash JE, Coutts AA. Furthe r evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol. 1996;118(8):2199-2205.
22. Aviello G, Romano B, Izzo AA. Cannabinoids and gastrointestinal motility: animal and human studies. Eur Rev Med Pharmacol Sci. 2008;12(suppl 1):81-93.
23. Alhouayek M, Muccioli GG. The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. Trends Mol Med. 2012;18(10):615-625.
24. Gomez R,et al A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding J Neurosci. 2002 22(21 9612-9617.
25. Storr MA, Sharkey KA. The endocannabinoid system and gut-brain signalling. Curr Opin Pharmacol. 2007;7(6):575-582.
26. Fu J, et al. Oleyle thanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-?. Nature. 2003;425(6953):90-93.
27. Piomelli D. A fatty gut feeling. Trends Endocrinol Metab. 2013;24(7):332-341.
28. Rodriguez de Fonseca F, et al. An anorexic lipid mediator regulated by feeding. Nature. 2001;414(6860):209-212.
29. Romano A, et al. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide. Physiol Behav. 2014;136:55-62.
30. Yang Y, Chen M, Georgeson KE, Harmon CM. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R235-R241.
31. Guz man M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-Activated receptor alpha (PPAR-?). J Biol Chem. 2004;279(27):27849-27854.
32. Suarez J, et al. Oleoylethanolamide enhances ?-Adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Dis Model Mech. 2014 ;7(1):129-141.
33. Overton HA, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006;3(3):167-175.
34. Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes. 2009;58(5):1058-1066.
35. Lan H, et al. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol. 2009;201(2):219-230.
36. Hans en KB, et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab. 2011;96(9):E1409-E1417.
37. Schwartz GJ, et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 2008;8(4):281-288.
38. Gaetani S, Oveisi F, Piomelli D. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology. 2003;28(7):1311-1316.
39. Gillum MP, et al. N-Acylphosphatidylethanolamine, a gut-derived circulating factor induced by fat ingestion, inhibits food intake. Cell. 2008;135(5):813-824.
40. Pollan M. The Omnivore's Dilemma: A Natural History of Four Meals. New York, New York, USA: Penguin Press; 2006.
41. Jiang P, et al. Major taste loss in carnivorous mammals. Proc Natl Acad Sci U S A. 2012;109(13):4956-4961.
42. Price SA, Hopkins SS, Smith KK, Roth VL. Tempo of trophic evolution and its impact on mammalian diversification. Proc Natl Acad Sci U S A. 2012;109(18):7008-7012.
43. Ingram T, Harmon LJ, Shurin JB. Niche evolution, trophic structure, and species turnover in model food webs. Am Nat. 2009;174(1):56-67.
44. Rangel A. Regulation of dietary choice by the decision-making circuitry. Nat Neurosci. 2013;16(12):1717-1724.
45. Small DM Flavor is in the brain Physiol Behav. 2012, 107, 4, 540-552.
46. Rolls ET. Neural representation of fat texture in the mouth. In: Montmayeur JP, le Coutre J, eds. Fat Detection: Taste, Texture, and Post Ingestive Effects. Boca Raton, Florida, USA; 2010:Chapter 8.
47. Mattes RD. Oral detection of short-, medium-, and long-chain free fatty acids in humans. Chem Senses. 2009;34(2):145-150.
48. Fukuwatari T, et al. Role of gustation in the recognition of oleate and triolein in anosmic rats. Physiol Behav. 2003;78(4-5):579-583.
49. Takeda M, Sawano S, Imaiz umi M, Fushiki T. Preference for corn oil in olfactory-blocked mice in the conditioned place preference test and the twobottle choice test. Lif Sci. 2001;69(7):847-854.
50. Breslin PA, Spector A C. Mammalian taste perception. Curr Biol. 2008;18(4):R148-R155.
51. Hamilton RB, Norgren R. Central projections of gustatory nerves in the rat. J Comp Neurol. 1984;222(4):560-577.
52. Grill HJ, Hayes MR. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab. 2012;16(3):296-309.
53. Carter ME, Soden ME, Zweifel LS, Palmiter RD. Genetic identification of a neural circuit that suppresses appetite. Nature. 2013;503(7474):111-114.
54. DiPatrizio NV, Simansky KJ. Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. J Neurosci. 2008;28(39):9702-9709.
55. Stratford JM, Curtis KS, Contreras RJ. Chorda tympani nerve transection alters linoleic acid taste discrimination by male and female rats. Physiol Behav. 2006;89(3):311-319.
56. Pittman D, Crawley ME, Corbin CH, Smith KR. Chorda tympani nerve transection impairs the gustatory detection of free fatty acids in male and female rats. Brain Res. 2007;1151:74-83.
57. Gaillard D, et al. The gustatory pathway is involved in CD36-mediated orosensory perception of long-chain fatty acids in the mouse. FASEB J. 2008;22(5):1458-1468.
58. Treesukosol Y, Blonde GD, Jiang E, Gonzalez D, Smith JC, Spector AC. Necessity of the glossopharyngeal nerve in the maintenance of normal intake and ingestive bout size of corn oil by rats. Am J Ph ysiol Regul Integr Comp Physiol. 2010;299(4):R1050-R1058.
59. Foo H, Norgren R. Concentration and state dependent reductions in corn oil intakes after glossopharyngeal nerve transections in rats. Physiol Behav. 2014;(128):166-171.
60. Liang NC, Hajnal A, Norgren R. Sham feeding corn oil increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol. 2006;291(5):R1236-R1239.
61. Adachi SI, et al. Increased levels of extracellular dopamine in the nucleus accumbens and amygdala of rats by ingesting a low concentration of a long-chain Fatty Acid. Biosci Biotechnol Biochem. 2013;77(11):2175-2180.
62. Mattes RD. Accumulating evidence supports a taste component for free fatty acids in humans. Physiol Behav. 2011;104(4):624-631.
63. DiPatrizio NV. Is fat taste r eady for primetime? Physiol Behav. 2014;136C:145-154.
64. Pepino MY, Love-Gregory L, Klein S, Abumrad NA. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. J Lipid Res. 2012;53(3):561-566.
65. Voigt N, et al. The role of lipolysis in human orosensory fat perception. J Lipid Res. 2014;55(5):870-882.
66. Kawai T, Fushiki T. Importance of lipolysis in oral cavity for orosensory detection of fat. Am J Physiol Regul Integr Comp Physiol. 2003;285(2):R447-R454.
67. Hamosh M, Scow RO. Lingual l ipase and its role in the digestion of dietary lipid. J Clin Invest. 1973;52(1):88-95.
68. Hamosh M, Burns WA. Lipolytic activity of human lingual glands (Ebner). Lab Invest. 1977;37(6):603-608.
69. Laugerette F, et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest. 2005;115(11):3177-3184.
70. Sclafani A, Ackroff K, Abumrad NA. CD36 gene deletion reduces fat preference and intake but not post-oral fat conditioning in mice. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):R18 23-R1832.
71. Cartoni C, et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci. 2010;30(25):8376-8382.
72. Liu P, Shah BP, Croasdell S, G ilbertson TA. Transient receptor potential channel type M5 is essential for fat taste. J Neurosci. 2011;31(23):8634-8642.
73. El-Yassimi A, Hichami A, Besnard P, Khan NA. Linoleic acid indu ces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells. J Biol Chem. 2008;283(19):12949-12959.
74. Chevrot M, et al. Obesity interfere s with the orosensory detection of long-chain fatty acids in humans. Am J Clin Nutr. 2014;99(5):975-983.
75. Feng P, Zheng J, Rossiter SJ, Wang D, Zhao H. Massive losses of taste receptor genes in toothed and baleen whales. Genome Biol Evol. 2014;6(6):1254-1265.
76. Zhao H, Yang JR, Xu H, Zh ang J. Pseudogenization of the umami taste receptor gene Tas1r1 in the giant panda coincided with its dietary switch to bamboo. Mol Biol Evol. 2010;27(12):2669-2673.
77. Greenberg D, Smith GP. The controls of fat intake. Psychosom Med. 1996;58(6):559-569.
78. Castro DC, Berridge KC. Advances in the neurobiological bases for food 'liking' versus 'wanting'. Physiol Behav. 2014;136:22-30.
79. Volkow ND1, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci. 2012;11:1-24.
80. DiLeone RJ, Taylor JR, Picciotto MR. The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction. Nat Neurosci. 2012;15(10):1330-1335.
81. Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12(11):638-651.
82. Avena NM, Bocarsly ME, Hoebel BG. Animal models of sugar and fat bingeing: relationship to food addiction and increased body weight. Methods Mol Biol. 2012;829:351-365.
83. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A. 2011;108(31):12904-12908.
84. DiPatrizio NV, Joslin A, Jung KM, Piomelli D. Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. FASEB J. 2013;27(6):2513-2520.
85. Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept. 2008;149(1-3):15-25.
86. Izzo AA, et al. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol. 2009;158(2):451-461.
87. Vianna CR, et al. Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. J Neurosci. 2012;32(30):10331-10337.
88. Senin LL,et al The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake PLoS One. 2013, 8, 11, e80339.
89. Sykaras AG, Demenis C, Case RM, McLaughlin JT, Smith CP. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One. 2012;7(8):e42 373.
90. Izzo AA, Sharkey KA. Cannabinoids and the gut: New developments and emerging concepts. Pharmacol Ther. 2010;126(1):21-38.
91. Hons IM, et al. Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling. Neurogastroenterol Motil. 2012;24(3):e113-e124.
92. Ji Y, et al. Activation of rat intestinal mucosal mast cells by fat absorption. Am J Physiol Gastrointest Liver Physiol. 2012;302(11):G1292-G1300.
93. Bellocchio L, et al. A ctivation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade. Proc Natl Acad Sci U S A. 2013;110(12):4786-4791.
94. Ferreira JG, Tellez LA, Ren X, Yeckel CW, de Araujo IE. Regulation of fat intake in the absence of flavour signalling. J Physiol. 2012;590(pt 4):953-972.
95. Ackroff K, Sclafani A. Oral and Postoral Determinants of dietary fat intake. In: Montmayeur JP, le Coutre J, eds. Fat Detection: Taste, Texture, and Post Ingestive Effects. Boca Raton, Florida, USA; 2010:Chapter 12.
96. Schwartz GJ. Gut fat sensing in the negative feedback control of energy balance-recent advances. Physiol Behav. 2011;104(4):621-623.
97. Ryan AT, et al. Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men. Am J Clin Nutr. 2013;98(2):300-311.
98. Yox DP, Stokesberry H, Ritter RC. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol. 1991;260(3 pt 2):R503-R508.
99. Tamura CS, Ritter RC. Intestinal capsaicin transiently attenuates suppression of sham feeding by oleate. Am J Physiol. 1994;267(2 pt 2):R561-R568.
100. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science. 1981;213(4511):1036-1037.
101. Yox DP , Brenner L, Ritter RC. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am J Physiol. 1992;262(4 pt 2):R554-R561.
102. Reimann F, Tolhurst G, Gribble F M. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15(4):421-431.
103. Shah BP, Liu P, Yu T, Hansen DR, Gilbertson TA. TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1. Am J Physiol Cell Physiol. 2012;302(1):C210-C219.
104. Hansen HS, Rosenkilde MM, Holst JJ, Schwartz TW. GPR119 as a fat sensor. Trends Pharmacol Sci. 2012;33(7):374-381.
105. Martin C, et al. Lipid-mediate d release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res. 2012;53(11):2256-2265.
106. Fu J, et al. Food intake regu lates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem. 2007;282(2):1518-1528.
107. Astarita G, et al. Postprandial increase of oleoylethanolamide mobilizati on in small intestine of the Burmese python (Python molurus). Am J Physiol Regul Integr Comp Physiol. 2006;290(5):R1407-R1412.
108. Tinoco AB, Armirotti A, Isorna E, Delgado MJ, Piomelli D, de Pedro N. Role of oleoylethanolamide as a feeding regulator in goldfish. J Exp Biol. 2014;217(pt 15):2761-2769.
109. Astarita G,et al Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties J Pharmacol Exp Ther. 2006, 318,2, 563-570.
110. Wellner N, Diep TA, Janfelt C, Hansen HS. N-Acylation of phosphatidylethanolamine and its biological functions in mammals. Biochim Biophys Acta. 2013;1831(3):652-662.
111. Campolongo P, et al. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci U S A. 2009;106(19):8027-8031.
112. Tellez LA, et al. A gut lipid messenger links excess dietary fat to dopamine deficiency. Science. 2013;341(6147):800-802.
113. Azari EK, et al. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide (OEA). Am J Physiol Regul Integr Comp Physiol. 2014;307(2):R167-R178.
114. Hazell GG, et al. G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei-serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol. 2012;33(1):45-66.
115. Sabatier N, Leng G, Menzies J. Oxytocin, feeding, and satiety. Front Endocrinol (Lausanne). 2013;4:35.
116. Gaetani S, et al. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci. 2010;30(24):8096-8101.
117. Romano A, et al. Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide. Am J Physiol Endocrinol Metab. 2013;305(1 0):E1266-E1273.
118. Provensi G, et al. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. Proc Natl Acad Sci U S A. 2014;111(31):11527-11532.
119. Sclafani A, Ackroff K, Schwartz GJ. Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients. Physiol Behav. 2003;78(2):285-294.
120. Fu J, et al. Sympathetic activity controls fatinduced oleoylethanolamide signaling in small intestine. J Neurosci. 2011;31(15):5730-5736.
121. Nasser Y, Ho W, Sharkey KA. Distribution of adrenergic receptors in the enteric nervous system of the guinea pig, mouse, and rat. J Comp Neurol. 2006;495(5):529-553.
122. Williams DL, et al. Maintenance on a high-fat diet impairs the anorexic response to glucagonlike-peptide-1 receptor activation. Physiol Behav. 2011;103(5):557-564.
123. Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes. 2003;52(2):252-259.
124. Artmann A, et al. Influence of dietary fatty acids on endocannabinoid and N-Acylethanolamine levels in rat brain, liv er and small intestine. Biochim Biophys Acta. 2008;1781(4):200-212.
125. Diep TA, et al. Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J. 2011;25(2):765-774.
126. Sam AH, Troke RC, Tan TM, Bewick GA. The role of the gut/brain axis in modulating food intake. Neuropharmacology. 2012;63(1):46-56.
127. M urphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006;444(7121):854-859.
128. Capasso R, Izzo AA. Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. J Neuroendocrinol. 2008;20(suppl 1):39-46.
129. Cluny NL, Keenan CM, Lutz B, Piomelli D, Sharkey KA. The identification of peroxisome prolif erator-Activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice. Neurogastroenterol Motil. 2009;21(4):420-429.
130. Aiello LC, Wheeler P. The expensive-tissue hypothesis. Curr Anthropol. 1995;36(2):199-221.